Description
hr070803, This randomized, double-blind, parallel-controlled, multicenter phase 3 study (NCT05074589) assessed the efficacy and safety of liposomal irinotecan HR070803 combined .
Beige and white GG Supreme canvas
irinotecan pancreatic cancer
Gold-toned hardware
irinotecan pancreatic cancer
Double G
Inside: 1 open pocket
nanoliposomal irinotecan
Chain top handle with 7″ drop
Top zip closure
liposome irinotecan
9.4″W x 1.4″H x 3.3″D
Weight: 0.6lbs approximately
pan heroic 1